Beta-2 microglobulin (B2M) is a cell surface protein that checks for cancer cell growth. It’s known as a tumor marker; it indicates that the cell is inflamed or performing abnormally. It can be found in blood or urine, and its discovery can indicate different diseases.
When CLL cells replicate, they release B2M into the blood. Doctors use the B2M test to assess the number of cancer cells in the body and their growth rate, and it also helps determine the response to treatment.
Are There Other Conditions That Affect B2M Levels?
Apart from leukemia and other types of cancer, B2M levels may be altered for patients with kidney disease, HIV/AIDS, and some autoimmune diseases. B2M can be found in the cerebral spinal fluid in some neurological disorders like multiple sclerosis.
The test relevant for CLL measures the concentration of B2M protein in the blood through a simple blood test. A healthcare professional will draw a blood sample, usually from a vein in your arm. The sample will be sent to a laboratory for analysis. Each lab may have a different B2M normal value range when reporting your results.
B2M can be found in other samples, such as urine, which is used mostly to evaluate specific kidney disorders. In rarer cases, a cerebrospinal fluid sample is extracted to test B2M in patients with neurological disorders. However, the blood sample version is the most commonly used method for blood cancer patients.
No special preparation is usually required for the B2M blood test. However, if you have any questions, consult your doctor.
The time frame to receive the results of your B2M test can vary depending on the laboratory and healthcare facility. Typically, results are available within a few days, but it can sometimes take up to a week. Your healthcare provider will inform you when to expect the results and how they will be communicated.
A healthcare professional familiar with your medical history and CLL should interpret your B2M test results. Here are some basic aspects of the B2M test so that you can understand what the test's values mean if you receive your results before your doctor.
In conclusion, the B2M test is helpful for monitoring chronic lymphocytic leukemia. By assessing how much of the B2M protein is in your blood (and/or urine), your doctor can interpret CLL progression. This information helps your doctor make informed decisions regarding your treatment.
To be up-to-date with CLL news, conferences, and treatment advances, you can subscribe to the HealthTree for CLL newsletter!
Source:
Beta-2 microglobulin (B2M) is a cell surface protein that checks for cancer cell growth. It’s known as a tumor marker; it indicates that the cell is inflamed or performing abnormally. It can be found in blood or urine, and its discovery can indicate different diseases.
When CLL cells replicate, they release B2M into the blood. Doctors use the B2M test to assess the number of cancer cells in the body and their growth rate, and it also helps determine the response to treatment.
Are There Other Conditions That Affect B2M Levels?
Apart from leukemia and other types of cancer, B2M levels may be altered for patients with kidney disease, HIV/AIDS, and some autoimmune diseases. B2M can be found in the cerebral spinal fluid in some neurological disorders like multiple sclerosis.
The test relevant for CLL measures the concentration of B2M protein in the blood through a simple blood test. A healthcare professional will draw a blood sample, usually from a vein in your arm. The sample will be sent to a laboratory for analysis. Each lab may have a different B2M normal value range when reporting your results.
B2M can be found in other samples, such as urine, which is used mostly to evaluate specific kidney disorders. In rarer cases, a cerebrospinal fluid sample is extracted to test B2M in patients with neurological disorders. However, the blood sample version is the most commonly used method for blood cancer patients.
No special preparation is usually required for the B2M blood test. However, if you have any questions, consult your doctor.
The time frame to receive the results of your B2M test can vary depending on the laboratory and healthcare facility. Typically, results are available within a few days, but it can sometimes take up to a week. Your healthcare provider will inform you when to expect the results and how they will be communicated.
A healthcare professional familiar with your medical history and CLL should interpret your B2M test results. Here are some basic aspects of the B2M test so that you can understand what the test's values mean if you receive your results before your doctor.
In conclusion, the B2M test is helpful for monitoring chronic lymphocytic leukemia. By assessing how much of the B2M protein is in your blood (and/or urine), your doctor can interpret CLL progression. This information helps your doctor make informed decisions regarding your treatment.
To be up-to-date with CLL news, conferences, and treatment advances, you can subscribe to the HealthTree for CLL newsletter!
Source:
about the author
Megan Heaps
Megan joined HealthTree in 2022. As a writer and the daughter of a blood cancer patient, she is dedicated to helping patients and their caregivers understand the various aspects of their disease. This understanding enables them to better advocate for themselves and improve their treatment outcomes. In her spare time, she enjoys spending time with her family.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.